Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice

European Respiratory Journal

Volumn 33, Issue 4, 2009, Pages 852-860

  Xu, T ^a,b   Qiao, J ^a   Zhao, L ^a   He, G ^a   Li, K ^a,b   Wang, J ^a   Tian, Y ^a,b   Wang, H ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b HEBEI NORTH UNIVERSITY   (China)

Author keywords

Acute respiratory distress syndrome; Cytokine; Dexamethasone; H5N1 avian influenza A virus

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD GAS ANALYSIS; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; FOOD INTAKE; HYPOXEMIA; INFLUENZA; INFLUENZA VIRUS A H5N1; INOCULATION; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ACUTE LUNG INJURY; ANIMALS; BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; GLUCOCORTICOIDS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; TUMOR NECROSIS FACTOR-ALPHA; WATER;

EID: 63849135869     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00130507     Document Type: Article

References (35)

1. Claas ECJ, Osterhaus ADME, Beek RV, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351: 472-477.
2. Chan PK. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002; 34: Suppl. 2, 58S-64S.
3. World Health Organization Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. Available from: www.who.int/csr/ disease/avian-influenza/country /cases-table-2008-04-15/en/index.html. Date last updated: April 15, 2008. Date last accessed: April 16, 2008.
4. Szretter KJ, Gangappa S, Lu XH, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81: 2736-2744.
5. Padgett DA, Loria RM, Sheridan JF. Steroid hormone regulation of antiviral immunity. Ann N Y Acad Sci 2000; 917: 935-943.
6. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004; 29: 480.
7. Moreno L, Jacoby DB, Fryer AD. Dexamethasone prevents virus-induced hyperresponsiveness via multiple mechanisms. Am J Physiol Lung Cell Mol Physiol 2003; 285: L451-L455.
8. Lee N, Sung J. The use of corticosteroids in SARS. N Engl J Med 2003; 348: 2034-2035.
9. Chen RC, Tang XP, Tan SY, Liang BL, Wan ZY, JQ, Zhong NS. Treatment of severe acute respiratory syndrome with glucosteroids. Chest 2006; 129: 1441-1452.
10. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280: 159-165.
11. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131: 954-963.
12. Samson SY, Wong MRC, Yuen KY. Avian influenza virus infections in humans. Chest 2006; 129: 156-178.
13. Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 1179-1188.
14. Centers for Disease Control and Prevention. Cases of influenza A (H5N1) - Thailand, 2004. MMWR Morb Mortal Rep 2004; 53: 100-103.
15. Xu T, Qiao J, Zhao LH, et al. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Care Med 2006; 174: 1011-1017.
16. Swayne DE, Halvorson DA. Influenza. In: Saif IYM, Barnes HJ, Glisson JR, Fadly AM, McDougald LR, Swayne DE, eds. Diseases of Poultry. Ames, Iowa State University Press, 2003; pp. 135-170.
17. Sadikot RT, Jansen ED, Blackwell TR, et al. High-dose dexamethasone accentuates nuclear factor-κB activation in endotoxin-treated mice. Am J Respir Care Med 2001; 164: 873-878.
18. Xiao S, Ling W, Yuanlin S, Chunxue B. Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide. Intensive Care Med 2004; 30: 133-140.
19. Lefort J, Motreff L, Vargaftig BB. Airway administration of Escherichia coli endotoxin to mice induces glucocorticosteroid-resistant bronchoconstriction and vasopermeation. Am J Respir Cell Mol Biol 2001; 24: 345-351.
20. Belperio JA, Keane MP, Burdick MD, et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 2002; 110: 1703-1716.
21. Germann PG, Hafner D. A rat model of acute respiratory distress syndrome (ARDS): part 1. Time dependency of histological and pathological changes. J Pharmacol Toxicol Methods 1998; 40: 101-107.
22. Lang JD, Figueroa M, Sanders KD, et al. Hypercapnia via reduced rate and tidal volume contributes to lipopolysaccharide-induced lung injury. Am J Respir Crit Care Med 2005; 171: 147-157.
23. Fagan KA, Fouty BW, Tyler RC, et al. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 1999;103: 291-299.
24. Majeski EI, Paintlia MK, Lopez AD, Harley RA, London SD, London L. Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol 2003; 163: 1467-1479.
25. Nick JA, Young SK, Brown KK, et al. Role of p38 mitogenactivated protein kinase in a murine model of pulmonary inflammation. J Immunol 2000; 164: 2151-2159.
26. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 2000; 74: 6105-6116.
27. Chan MCW, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6: 135.
28. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12: 1203-1207.
29. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
30. Meduri GU, Chinn A, Leeper K, et al. The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J 1996; 9: 2650-2670.
31. Ottolini M, Blanco J, Porter D, Peterson L, Curtis S, Prince G. Combination of anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol 2003; 36: 290-294.
32. London L, Majeski EI, Altman-Hamamdzic S, et al. Respiratory reovirus 1/L induction of diffuse alveolar damage: pulmonary fibrosis is not modulated by glucosteroids in acute respiratory distress syndrome in mice. Clin Immunol 2002; 103: 284-295.
33. Carter MJ. A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J Med Microbiol 2007; 56: 875-883.
34. van Woensel JB, Lutter R, Biezeveld MH, et al. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection. Pediatr Infect Dis J 2003; 22: 721-726.
35. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374-1385.